Use of growth hormone secretagogues for stimulating or increasing appetite
CA 2351902 A1 · Owner: Pan, Lydia Codetta · Inventors: Friedman, Hylar Lewis; Landschulz, William Harras; Pan, Lydia Codetta
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein is a drug for increasing or stimulating appetite in a patient, which comprises an effective amount of a certain growth hormone secretagogue a prodrug, thereof or a pharmaceutically acceptable salt of the secretagogue or the prodrug. More preferably the growth, hormone secretagogue is a compound of Formula I: (see formula I), (in which HET is a heterocyclic moiety; R3 is alkyl or the like; R4 is H, alkyl or the like; X4 is H or alkyl; R6 is a bond alkylene or the like; R7 and R8 are H, alkyl or the like) such as 2-amino-N-2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7hexahydropyrazolo4,3-cpyridin-5-yl)-l-(R)-benzyloxymethyl-2oxo-ethylisobutylamide, a prodrug thereof or a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.